Q3 2025 Holdings
Filed 2025-11-14 | 21 holdings | $1.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Heartflow Inc(HTFL) | COM | 42238D107 | $419.0M | 12,448,158 | 27.8% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $304.9M | 10,719,110 | 20.2% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $289.3M | 3,020,990 | 19.2% |
| Pharvaris N V(PHVS) | COM | N69605108 | $79.4M | 3,181,275 | 5.3% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $67.0M | 6,843,954 | 4.4% |
| Savara Inc(SVRA) | COM | 805111101 | $62.8M | 17,600,621 | 4.2% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $51.8M | 1,315,892 | 3.4% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $48.8M | 7,911,669 | 3.2% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $45.9M | 2,439,538 | 3.0% |
| Rapid Micro Biosystems Inc(RPID) | CLASS A COM | 75340L104 | $28.2M | 8,434,560 | 1.9% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $22.8M | 2,712,008 | 1.5% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $22.6M | 9,677,125 | 1.5% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $20.2M | 3,368,370 | 1.3% |
| Annexon Inc(ANNX) | COM | 03589W102 | $16.0M | 5,249,069 | 1.1% |
| X4 Pharmaceuticals Inc(XFOR) | COM NEW | 98420X202 | $8.3M | 2,436,588 | 0.6% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $7.2M | 2,485,638 | 0.5% |
| Xilio Therapeutics Inc(XLO) | COM | 98422T100 | $3.8M | 4,566,817 | 0.3% |
| Mersana Therapeutics Inc(MRSN) | COM | 59045L205 | $2.7M | 346,545 | 0.2% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $2.5M | 1,111,910 | 0.2% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $1.8M | 3,538,609 | 0.1% |
| Newamsterdam Pharma Company | *W EXP 99/99/999 | N62509117 | $1.7M | 100,000 | 0.1% |